CDK9: A Comprehensive Review of Its Biology, and Its Role as a Potential Target for Anti-Cancer Agents
Cyclin-dependent kinases (CDKs) are proteins pivotal to a wide range of cellular functions, most importantly cell division and transcription, and their dysregulations have been implicated as prominent drivers of tumorigenesis. Besides the well-established role of cell cycle CDKs in cancer, the invol...
Main Authors: | Abel Tesfaye Anshabo, Robert Milne, Shudong Wang, Hugo Albrecht |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.678559/full |
Similar Items
-
Selective CDK9 Inhibition by Natural Compound Toyocamycin in Cancer Cells
by: Somnath Pandey, et al.
Published: (2022-07-01) -
CDK9 inhibitors in acute myeloid leukemia
by: Silvia Boffo, et al.
Published: (2018-02-01) -
The Flavonoid Metabolite 2,4,6-Trihydroxybenzoic Acid Is a CDK Inhibitor and an Anti-Proliferative Agent: A Potential Role in Cancer Prevention
by: Ranjini Sankaranarayanan, et al.
Published: (2019-03-01) -
HIV Tat/P-TEFb Interaction: A Potential Target for Novel Anti-HIV Therapies
by: Kaori Asamitsu, et al.
Published: (2018-04-01) -
An Orally Bioavailable and Highly Efficacious Inhibitor of CDK9/FLT3 for the Treatment of Acute Myeloid Leukemia
by: Abel Tesfaye Anshabo, et al.
Published: (2022-02-01)